Rocío Isabel
Rodríguez Macías
Catedrática de Universidad
Instituto de Salud Carlos III
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Instituto de Salud Carlos III (5)
2023
-
Mitochondrial RNA methyltransferase TRMT61B is a new, potential biomarker and therapeutic target for highly aneuploid cancers
Cell Death and Differentiation, Vol. 30, Núm. 1, pp. 37-53
-
Relevance of the organic anion transporting polypeptide 1B3 (OATP1B3) in the personalized pharmacological treatment of hepatocellular carcinoma
Biochemical Pharmacology, Vol. 214
2021
-
Novel pharmacological options in the treatment of cholangiocarcinoma: Mechanisms of resistance
Cancers, Vol. 13, Núm. 10
2019
-
Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib
British Journal of Pharmacology, Vol. 176, Núm. 6, pp. 787-800
2002
-
Evidence for dual effects of DNA-reactive bile acid derivatives (Bamets) on hepatitis B virus life cycle in an in vitro replicative system
Antiviral Chemistry and Chemotherapy, Vol. 13, Núm. 6, pp. 371-380